Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Non Operating Interest Expenses (2023 - 2026)

Bioregenx (BRGX) posted Non Operating Interest Expenses of $77086.0 for Q1 2026, down 6.16% on a QoQ basis from $82147.0 in Q4 2025, and up 3.83% year-over-year from $74239.0 in Q1 2025.

Analysis

Bioregenx (BRGX) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends

Bioregenx has reported Non Operating Interest Expenses for 4 years, with the latest figure at $77086.0 in Q1 2026.

  • On a quarterly basis, Non Operating Interest Expenses rose 3.83% year-over-year to $77086.0 in Q1 2026; TTM through Mar 2026 was $302425.0, a 3.61% increase from a year earlier, with the FY2025 full-year figure at $299578.0, up 3.07% from the prior year.
  • Non Operating Interest Expenses was $77086.0 for Q1 2026 at Bioregenx, down from $82147.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $83756.0 in Q4 2024, with the low at $45193.0 in Q4 2023.
  • Average Non Operating Interest Expenses over 4 years is $66044.4, with a median of $71086.0 recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses surged 85.33% in 2024, then decreased 1.92% in 2025.
  • Over 4 years, Non Operating Interest Expenses stood at $45193.0 in 2023, then soared by 85.33% to $83756.0 in 2024, then fell by 1.92% to $82147.0 in 2025, then decreased by 6.16% to $77086.0 in 2026.
  • The last three Non Operating Interest Expenses figures came in at $77086.0 (Q1 2026), $82147.0 (Q4 2025), and $72106.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 351.00 Mn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn -
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 186.00 Mn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 141.00 Mn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 96.00 Mn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn -
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn -
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn -
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -53.00 Mn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 77,086.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 77,086.00
Dec 31, 2025 82,147.00
Sep 30, 2025 72,106.00
Jun 30, 2025 71,086.00
Mar 31, 2025 74,239.00
Dec 31, 2024 83,756.00
Sep 30, 2024 67,553.00
Jun 30, 2024 66,331.00
Mar 31, 2024 73,022.00
Dec 31, 2023 45,193.00
Sep 30, 2023 50,482.00
Jun 30, 2023 49,843.00
Mar 31, 2023 45,733.00
API Access

Bioregenx Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BRGX&period=max&api_key=YOUR_API_KEY